0001299130-24-000200.txt : 20241213 0001299130-24-000200.hdr.sgml : 20241213 20241213165629 ACCESSION NUMBER: 0001299130-24-000200 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20241211 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20241213 DATE AS OF CHANGE: 20241213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 241549141 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 8-K 1 pacb-20241211.htm 8-K pacb-20241211
0001299130false00012991302024-12-112024-12-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
December 11, 2024
Pacific Biosciences of California, Inc.
(Exact name of registrant as specified in its charter)
Delaware001-3489916-1590339
(State or other jurisdiction
of incorporation)		(Commission
File Number)		(IRS Employer
Identification No.)
1305 O’Brien Drive
Menlo Park, California 94025
(Address of principal executive offices) (Zip Code)
(650) 521-8000
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per sharePACBThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


ITEM 5.02.    DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

The Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Pacific Biosciences of California, Inc. (the “Company”) and the Board approved the following amendments to the Company’s change in control and severance agreement for Christian O. Henry, the President and Chief Executive Officer of the Company, and Mark Van Oene, Chief Operating Officer of the Company, on December 11, 2024 and December 12, 2024, respectively:

•Any salary severance is to be paid in a lump sum cash payment equal to twelve months (or eighteen months in the case of Mr. Henry) of the executive’s base salary.
•The change of control period under the agreement is to include the three months prior to the occurrence of a change in control in addition to the twelve months following the change in control.

The Committee also amended and restated the Company’s current form of change in control and severance agreement for executive officers to reflect these amendments.

The Company entered into amended and restated change in control and severance agreements with each of Mr. Henry and Mr. Van Oene reflecting these amendments.

This description of the amended and restated change in control and severance agreements with each of Mr. Henry and Mr. Van Oene and the form of change in control and severance agreement for executive officers is qualified in its entirety by reference to the full text of the such agreements, which the Company intends to file as exhibits to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.





SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Pacific Biosciences of California, Inc.
By:/s/ Brett Atkins
Brett Atkins
General Counsel
Date: December 13, 2024

 EX-101.SCH 2 pacb-20241211.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 pacb-20241211_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cover [Abstract] Written Communications Written Communications Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security City Area Code City Area Code Document Period End Date Document Period End Date Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Pre-commencement Tender Offer Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 pacb-20241211_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.3
Cover Page
Dec. 11, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Dec. 11, 2024
Entity Registrant Name Pacific Biosciences of California, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-34899
Entity Tax Identification Number 16-1590339
Entity Address, Address Line One 1305 O’Brien Drive
Entity Address, City or Town Menlo Park
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94025
City Area Code 650
Local Phone Number 521-8000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol PACB
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001299130
Amendment Flag false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.pacificbiosciences.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports pacb-20241211.htm pacb-20241211.xsd pacb-20241211_lab.xml pacb-20241211_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "pacb-20241211.htm": { "nsprefix": "pacb", "nsuri": "http://www.pacificbiosciences.com/20241211", "dts": { "inline": { "local": [ "pacb-20241211.htm" ] }, "schema": { "local": [ "pacb-20241211.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd" ] }, "labelLink": { "local": [ "pacb-20241211_lab.xml" ] }, "presentationLink": { "local": [ "pacb-20241211_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://www.pacificbiosciences.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pacb-20241211.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pacb-20241211.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.pacificbiosciences.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001299130-24-000200-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001299130-24-000200-xbrl.zip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end XML 15 pacb-20241211_htm.xml IDEA: XBRL DOCUMENT 0001299130 2024-12-11 2024-12-11 0001299130 false 8-K 2024-12-11 Pacific Biosciences of California, Inc. DE 001-34899 16-1590339 1305 O’Brien Drive Menlo Park CA 94025 650 521-8000 false false false false Common Stock, par value $0.001 per share PACB NASDAQ false